Krumholz H M, Radford M J, Ellerbeck E F, Hennen J, Meehan T P, Petrillo M, Wang Y, Jencks S F
Cardiovascular Section, Yale School of Medicine, New Haven, CT 06520-8017, USA.
Ann Intern Med. 1996 Feb 1;124(3):292-8. doi: 10.7326/0003-4819-124-3-199602010-00002.
To determine how often aspirin was prescribed as a discharge medication to eligible patients 65 years of age and older who were hospitalized with an acute myocardial infarction; to identify patient characteristics associated with the decision to use aspirin; and to evaluate the association between prescription of aspirin at discharge and 6-month survival.
Observational study.
All 352 nongovernment, acute care hospitals in Alabama, Connecticut, Iowa, and Wisconsin.
5490 consecutive Medicare beneficiaries who survived an acute myocardial infarction, were hospitalized between June 1992 and February 1993, and did not have a contraindication to aspirin.
Medical charts were reviewed to obtain information on the prescription of aspirin at discharge, contraindications, patient demographic characteristics, and clinical factors.
4149 patients (76%) were prescribed aspirin at hospital discharge. In a multivariable analysis, an increased prescribed use of aspirin at discharge was correlated with several indicators of better overall health status (better left ventricular ejection fraction, absence of diabetes, shorter length of hospital stay, higher albumin level, and discharge to the patient's home). The prescribed use of aspirin at discharge was also associated with several specific patterns of care, including the use of cardiac procedures, beta-blocker therapy at discharge, and aspirin during the hospitalization. The prescribed use of aspirin at discharge was associated with a lower mortality rate 6 months after discharge compared with no prescribed aspirin (odds ratio, 0.77; 95% CI, 0.61 to 0.98), even after adjustment for baseline differences in demographic, clinical, and treatment characteristics between the two groups.
Aspirin was not prescribed at discharge to 24% of elderly patients who were hospitalized with an acute myocardial infarction and did not have a contraindication to aspirin. Several patient characteristics were associated with a higher risk for not being prescribed aspirin. Increasing the prescription of aspirin for these patients may provide an excellent opportunity to improve their care.
确定在因急性心肌梗死住院的65岁及以上符合条件的患者中,阿司匹林作为出院用药的处方频率;确定与使用阿司匹林这一决定相关的患者特征;并评估出院时阿司匹林处方与6个月生存率之间的关联。
观察性研究。
阿拉巴马州、康涅狄格州、爱荷华州和威斯康星州的所有352家非政府急性护理医院。
5490名连续的医疗保险受益人,他们在急性心肌梗死后存活,于1992年6月至1993年2月期间住院,且无阿司匹林使用禁忌证。
查阅病历以获取出院时阿司匹林处方、禁忌证、患者人口统计学特征和临床因素等信息。
4149名患者(76%)在出院时被处方使用阿司匹林。在多变量分析中,出院时阿司匹林处方使用增加与整体健康状况较好的几个指标相关(左心室射血分数更高、无糖尿病、住院时间更短、白蛋白水平更高以及出院回家)。出院时阿司匹林的处方使用还与几种特定的护理模式相关,包括心脏手术的使用、出院时的β受体阻滞剂治疗以及住院期间使用阿司匹林。与未处方使用阿司匹林相比,出院时处方使用阿司匹林与出院后6个月较低的死亡率相关(比值比,0.77;95%置信区间,0.61至0.98),即使在对两组间人口统计学、临床和治疗特征的基线差异进行调整之后也是如此。
24%因急性心肌梗死住院且无阿司匹林使用禁忌证的老年患者在出院时未被处方使用阿司匹林。几个患者特征与未被处方使用阿司匹林的较高风险相关。增加这些患者的阿司匹林处方可能是改善其护理的绝佳机会。